Research programme: superoxide dismutase mimics - SIDR

Drug Profile

Research programme: superoxide dismutase mimics - SIDR

Alternative Names: Research programme: superoxide dismutase mimics - Strathclyde Institute for Drug Research; Superoxide dismutase mimics research programme - SIDR; Superoxide dismutase mimics research programme - Strathclyde Institute for Drug Research

Latest Information Update: 04 Aug 2004

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Strathclyde Institute for Drug Research
  • Class
  • Mechanism of Action Free radical scavengers; Superoxide dismutase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 04 Aug 2004 Discontinued - Preclinical for Cancer in United Kingdom (unspecified route)
  • 20 Jul 1999 Available for licensing (http://www.sidr.org)
  • 20 Jul 1999 Preclinical development for Cancer in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top